ARQT (STOCKS)
Arcutis Biotherapeutics, Inc. Common Stock
$26.000000
+1.620000 (+6.64%)
Prev close: $24.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Todd Franklin Watanabe
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,203.39M
- Employees
- 342
- P/E (TTM)
- -858.45
- P/B (TTM)
- 16.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.09 | $-0.08 | -0.0062 | -7.40% |
|
Dec 2025 (Q4)
|
$0.13 | $0.12 | +0.0143 | +12.36% |
|
Sep 2025 (Q3)
|
$0.06 | $-0.10 | +0.1619 | +158.88% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.16 | +0.0313 | +19.40% |
Financial Statements
| Revenues | $415.62M |
| Benefits Costs and Expenses | $412.41M |
| Cost Of Revenue | $37.65M |
| Costs And Expenses | $412.41M |
| Gross Profit | $377.98M |
| Operating Expenses | $374.76M |
| Selling, General, and Administrative Expenses | $284.63M |
| Research and Development | $90.14M |
| Operating Income/Loss | $3.21M |
| Income/Loss From Continuing Operations After Tax | -$2.38M |
| Income/Loss From Continuing Operations Before Tax | $1.94M |
| Income Tax Expense/Benefit | $985.00K |
| Net Income/Loss | -$2.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.03 |
| Diluted Earnings Per Share | -$0.03 |
| Basic Average Shares | 255,092,365 |
| Diluted Average Shares | 260,354,365 |
| Assets | $460.00M |
| Current Assets | $438.06M |
| Inventory | $37.39M |
| Other Current Assets | $400.67M |
| Noncurrent Assets | $21.95M |
| Fixed Assets | $1.04M |
| Intangible Assets | $14.25M |
| Other Non-current Assets | $6.66M |
| Liabilities | $270.36M |
| Current Liabilities | $163.20M |
| Accounts Payable | $18.30M |
| Wages | $10.32M |
| Other Current Liabilities | $134.58M |
| Noncurrent Liabilities | $107.15M |
| Long-term Debt | $109.42M |
| Equity | $189.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $189.65M |
| Liabilities And Equity | $460.00M |
| Net Cash Flow From Operating Activities | $26.99M |
| Net Cash Flow From Operating Activities, Continuing | $26.99M |
| Net Cash Flow From Investing Activities | -$53.34M |
| Net Cash Flow From Investing Activities, Continuing | -$53.34M |
| Net Cash Flow From Financing Activities | $7.65M |
| Net Cash Flow From Financing Activities, Continuing | $7.65M |
| Net Cash Flow | -$18.70M |
| Net Cash Flow, Continuing | -$18.70M |
| Comprehensive Income/Loss | -$2.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.75M |
| Other Comprehensive Income/Loss | $13.03M |
| Other Comprehensive Income/Loss Attributable To Parent | -$374.00K |